viernes, 23 de noviembre de 2018

NIAID Email Alert: ART Optimization R61/R33

NIAID Logo

Funding Opportunity

  • RFA-AI-18-057, Long-Acting Drug Delivery Systems for ART Optimization in HIV-1 Infected Children (R61/R33 Clinical Trial Not Allowed)
You can follow us on Twitter: @NIAIDFunding.

No hay comentarios: